Publications:

---

Fluoxetine pharmacokinetics and tissue distribution quantitatively supports a therapeutic role in COVID-19 at a minimum dose of 20 mg per day.

F1000Research

Eugene, Andy R AR

Publication Date: 2021

Variant appearance in text: ADR: E484K

PubMed Link: 36262792

Variant Present in the following documents:

• Main text
• f1000research-10-136846.pdf

View BVdb publication page

---

Comparative Efficacy of Early COVID-19 Monoclonal Antibody Therapies: A Retrospective Analysis.

Open Forum Infectious Diseases

San Filippo, Savanna S; Crovetto, Brynna B; Bucek, John J; Nahass, Ronald G RG; Milano, Marc M; Brunetti, Luigi L

Publication Date: 2022-04

Variant appearance in text: ADR: E484K

PubMed Link: 35299987

Variant Present in the following documents:

• Main text
• ofac080.pdf

View BVdb publication page

---

Effectiveness and Efficacy of Vaccine on Mutated SARS-CoV-2 Virus and Post Vaccination Surveillance: A Narrative Review.

Vaccines

Hafiz, Ihsanul I; Illian, Didi Nurhadi DN; Meila, Okpri O; Utomo, Ahmad Rusdan Handoyo ARH; Susilowati, Arida A; Susetya, Ipanna Enggar IE; Desrita, Desrita D; Siregar, Gontar Alamsyah GA; Basyuni, Mohammad M

Publication Date: 2022-01-06

Variant appearance in text: ADR: E484K

PubMed Link: 35062743

Variant Present in the following documents:

• Main text
• vaccines-10-00082.pdf

View BVdb publication page

---

Effectiveness and Efficacy of Vaccine on Mutated SARS-CoV-2 Virus and Post Vaccination Surveillance: A Narrative Review.

Vaccines

Hafiz, Ihsanul I; Illian, Didi Nurhadi DN; Meila, Okpri O; Utomo, Ahmad Rusdan Handoyo ARH; Susilowati, Arida A; Susetya, Ipanna Enggar IE; Desrita, Desrita D; Siregar, Gontar Alamsyah GA; Basyuni, Mohammad M

Publication Date: 2022-01-06

Variant appearance in text: ADR: E484K

PubMed Link: 35062743

Variant Present in the following documents:

• Main text
• vaccines-10-00082.pdf

View BVdb publication page

---

An Overview of the Epidemiologic, Diagnostic and Treatment Approaches of COVID-19: What do We Know?

Public Health Reviews

Beyrampour-Basmenj, Hanieh H; Milani, Morteza M; Ebrahimi-Kalan, Abbas A; Ben Taleb, Ziyad Z; Ward, Kenneth D KD; Dargahi Abbasabad, Ghader G; Aliyari-Serej, Zeynab Z; Ebrahimi Kalan, Mohammad M

Publication Date: 2021

Variant appearance in text: ADR: E484K

PubMed Link: 34381626

Variant Present in the following documents:

• Main text
• phrs-42-1604061.pdf

View BVdb publication page

---

An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future.

Expert Opinion On Drug Discovery

Tuccori, Marco M; Convertino, Irma I; Ferraro, Sara S; Valdiserra, Giulia G; Cappello, Emiliano E; Fini, Elisabetta E; Focosi, Daniele D

Publication Date: 2021-12

Variant appearance in text: ADR: E484K

PubMed Link: 34304682

Variant Present in the following documents:

• Main text
• IEDC_0_1960819.pdf

View BVdb publication page

---

Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria?

Journal Of Medical Virology

Chirumbolo, Salvatore S

Publication Date: 2021-07

Variant appearance in text: ADR: E484K

PubMed Link: 33666240

Variant Present in the following documents:

• JMV-9999-0.pdf

View BVdb publication page

---